论文部分内容阅读
本文选择了头孢呋辛、氨苄西林-舒巴坦钠、头孢吡肟3种静脉用抗生素治疗下呼吸道感染的方案。临床有效率分别为86.84%、80.00%、95.24%。运用药物经济学成本效用分析方法,得出其成本-效用比分别为2413.36元、3597.31元、4393.85元。头孢呋辛的治疗方案是最有效、安全、经济。利用此分类方法可为我国有限的医疗资源合理分配提供依据。
This article chose cefuroxime, ampicillin - sulbactam sodium, cefepime intravenous antibiotics for the treatment of lower respiratory tract infection program. The clinical effective rates were 86.84%, 80.00% and 95.24% respectively. Using cost-utility analysis of pharmacoeconomics, we found that the cost-utility ratio was 2413.36 yuan, 3597.31 yuan and 4393.85 yuan respectively. Cefuroxime treatment is the most effective, safe and economical. Using this classification method can provide the basis for the reasonable distribution of limited medical resources in our country.